by Osel | Oct 29, 2015 | CBM588 CLINICAL
Yasueda A, Mizushima T, Nezu R, Sumi R, Tanaka M, Nishimura J, Kai Y, Hirota M, Osawa H, Nakajima K, Mori M, Ito T. Synopsis: A randomized, placebo-controlled study was performed on 17 patients with ulcerative colitis who had under gone ileal pouch anal...
by Osel | Sep 19, 2012 | CBM588 CLINICAL
Sato S, Nagai H, Igarashi Y. Hepatogastroenterology. 2012 Sep;59(118):1804-8. Synopsis: During enterohepatic circulation, the intestinal microbiota causes 7 alpha-dehydroxylation of cholic acid (CA) and chenodeoxycholic acid (CDCA), yielding deoxycholic...
by Osel | Mar 19, 2008 | CBM588 CLINICAL
Imase K, Takahashi M, Tanaka A, Tokunaga K, Sugano H, Tanaka M, Ishida H, Kamiya S, Takahashi S. Microbiol Immunol. 2008 Mar;52(3):156-61. doi: 10.1111/j.1348-0421.2008.00026.x. Synopsis: Antibiotic associated diarrhea due to human intestinal microbiota...
by Osel | Dec 21, 2005 | CBM588 CLINICAL
Shimbo I, Yamaguchi T, Odaka T, Nakajima K, Koide A, Koyama H, Saisho H. World J Gastroenterol. 2005 Dec 21;11(47):7520-4. Synopsis: This study investigated the effect of Clostridium butyricum MIYAIRI 588 (CBM) on the fecal microbiota during antibiotic...
by Osel | Feb 19, 2003 | CBM588 CLINICAL
Seki H, Shiohara M, Matsumura T, Miyagawa N, Tanaka M, Komiyama A, Kurata S. Pediatr Int. 2003 Feb;45(1):86-90. Synopsis: The preventive effect of CBM was investigated for antibiotic-associated diarrhea (AAD) in children. One hundred and ten children who...